Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production ...
The fall in Cipla share price today comes after the pharma major disclosed that manufacturing of Lanreotide has been ...
The production of Lanreotide had to be temporarily halted by Cipla after the USFDA inspection at its contract manufacturer ...
Cipla shares fell sharply on Friday after a halt in Lanreotide Injection production due to USFDA observations at its Greek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results